This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

With MedInformatix Patient Portal, Indiana Eye Practice Sees Increased Traffic Ahead





INDIANAPOLIS, Ind., April 2, 2013 /PRNewswire/ -- With the addition of the MedInformatix Patient Portal Module to its Electronic Health Records (EHR) and Practice Management (PM) platform, Price Vision Group anticipates its patient capacity to increase by more than 15 percent in 2013. Using the secure portal, patients can answer questions about their medical history well before the visit, eliminating the need to fill out responses on a clipboard upon arrival and reducing the overall time they spend in the office.

Price Vision Group, which is owned by Francis W. Price Jr., M.D., a cornea subspecialist who trains ophthalmic surgeons from around the world at the site, is the leading standalone U.S. practice for cornea transplants, logging more than 600 procedures annually. Through the portal, the practice aims to enhance the patient experience through education, making available streaming video of procedures such as various cornea transplants and cataract surgery.

Once installed by May, the MedInformatix Patient Portal will provide patients with an online questionnaire that is attractive and easy to navigate, unlike the practice's existing one-size-fits-all product that requires patients to click cells against a gray interface and answer questions not necessarily designed for ophthalmology. The new portal will complete a triad of MedInfomatix products, enabling patient data to be entered and shared seamlessly, in a line-for-line match, from one module to another.

Timing for these streamlined processes couldn't be better given cost pressures due to reimbursement cuts and rising overhead. "We need some way of expediting patients," said Tony Sterrett, Practice Administrator. "Introducing the new portal not only makes life easier for the patient, but also it helps us."

The MedInformatix Patient Portal enables patients to initiate and complete routine administrative tasks from home computers or mobile devices without the worry of privacy breaches. The module features encrypted transmission and is compliant with the Health Insurance Portability and Accountability Act (HIPAA). The portal's capabilities include the following:

  • Appointments – Patients can describe their medical condition, select an option from available appointments and submit an appointment request online.
  • Insurance – Patients can select their insurance carrier in a dropdown menu, update information and make payments online via credit card.
  • Prescription Refills – Through integration with the MedInformatix E-Prescribing Module, patients can request refills and upon approval by the practice, have the request routed to their preferred pharmacy for pickup.
  • Patient History – Before appointments, patients can complete family and medical history and demographic data, and list active medications and dosages on the portal.  A practice physician later reviews the information with the patient in person to confirm accuracy.

Other components of the MedInformatix product suite, the EHR and PM, provide ample support to the busy practice that sees 18,750 patients annually and a stream of eye surgeons who sharpen their skills by watching Dr. Price or by working on human tissue in wet labs. The modules automate a bevy of key tasks from patient charting to tracking physician productivity to distinguishing Level II and Level III procedures for custom financial reporting.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,677.90 +216.58 1.32%
S&P 500 1,950.82 +23.71 1.23%
NASDAQ 4,452.7920 +69.9450 1.60%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs